Skip to main content
. 2021 Mar 27;14(6):101083. doi: 10.1016/j.tranon.2021.101083

Fig. 2.

Fig. 2

Pooled hazard ratio for overall survival (A), progression-free survival (B), and pooled odds ratio for objective response rate (C) in advanced esophageal cancer treated with anti-PD-1 versus chemotherapy. (HR: Hazard ratio; OR: Odds ratio; CI: Confidence interval; and PD-1: Programmed cell death 1).